Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Más filtros

Intervalo de año de publicación
1.
Isr Med Assoc J ; 22(4): 236-240, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32286027

RESUMEN

BACKGROUND: Urinary tract infection (UTI) is a common bacterial infection in children. ​​​​​​​Early treatment may prevent renal damage in pyelonephritis. The choice of empiric antibiotic treatment is based on knowledge of the local susceptibility of urinary bacteria to antibiotics. In Israel the recommended empiric oral antibiotic treatment are First or second generation cephalosporin, trimethoprim-sulfamethoxazole or amoxicillin-clavulanic acid. OBJECTIVES: To describe resistance rates of urine bacteria isolated from children with UTI in the community settings. Identify risk factors for resistance. METHODS: A retrospective cross-sectional study of UTI in children aged 3 months to 18 years diagnosed with UTI and treated as outpatients in a large community clinic between 7/2015 and 7/2017 with a diagnosis of UTI. RESULTS: A total of 989 urinary samples were isolated, 232 were included in the study. Resistance rates to cephalexin, cefuroxime, ampicillin/clavulanate and Trimethoprim-Sulfamethoxazole were 9.9%, 9.1%, 20.7%, and 16.5%, respectively. Urinary tract abnormalities and recurrent UTI were associated with an increase in antibiotic resistance rates. Other factors such as age, fever, and previous antibiotic treatment were not associated with resistance differences. CONCLUSIONS: Resistance rates to common oral antibiotics were low compared to previous studies performed in Israel in hospital settings. First generation cephalosporins are the preferred empiric antibiotics for febrile UTI for outpatient children. Amoxicillin/clavulanate is not favorable due to resistance of over 20% and the broad spectrum of this antibiotic. Care should be taken in children with renal abnormalities as there is a worrying degree of resistance rates to the oral first line antibiotic therapy.


Asunto(s)
Combinación Amoxicilina-Clavulanato de Potasio/uso terapéutico , Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Adolescente , Factores de Edad , Distribución de Chi-Cuadrado , Niño , Preescolar , Estudios Transversales , Femenino , Estudios de Seguimiento , Humanos , Lactante , Israel , Masculino , Pruebas de Sensibilidad Microbiana , Pacientes Ambulatorios/estadística & datos numéricos , Estudios Retrospectivos , Medición de Riesgo , Factores Sexuales , Estadísticas no Paramétricas , Resultado del Tratamiento , Urinálisis/métodos , Infecciones Urinarias/fisiopatología , Urodinámica/fisiología
2.
JNMA J Nepal Med Assoc ; 58(221): 11-14, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-32335632

RESUMEN

INTRODUCTION: Urinary tract infection is one of the commonest causes of childhood morbidity. Early diagnosis and appropriate choice of antimicrobials is essential. Hence, this study aims to identify the prevalence of Escherichia coli in childhood urinary tract infections. METHODS: This was a hospital based descriptive cross-sectional study conducted in Nobel Medical College, Biratnagar over a period of one year. A total of 163 cases aged 1-15 years were included and clinical profile, laboratory reports including bacterial isolates in urine cultures and their sensitivity patterns were documented. RESULTS: The prevalence of Escherichia coli is 45 (53.57%) C.I. Escherichia coli was the most common organism isolated in bacterial cultures followed by Klebsiella 12 (14.29%), Enterococcus 10 (11.90%). Urinary tract infection was common among females with male: female ratio of 1:2.3. Fever 152 (93.2%) and abdominal pain 113 (69.3%) were the most common presenting symptoms. Escherichia coli was found most sensitive to Nitrofurantoin 43 (95.5%) followed by Ciprofloxacin 41 (91.1%) and Amikacin 40 (88.8%). CONCLUSIONS: Urinary tract infections in childhood require prompt attention and treatment to prevent significant morbidity and mortality. From this study it can be concluded that Escherichia coli is one of the most common isolates in urine culture and Aminoglycosides and Fluoroquinolones can be accepted as empirical treatment regimens for childhood Urinary tract infections.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Escherichia coli , Escherichia coli/aislamiento & purificación , Infecciones Urinarias , Adolescente , Antibacterianos/clasificación , Niño , Estudios Transversales , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/fisiopatología , Infecciones por Escherichia coli/terapia , Femenino , Humanos , Lactante , Masculino , Pruebas de Sensibilidad Microbiana/métodos , Pruebas de Sensibilidad Microbiana/estadística & datos numéricos , Nepal/epidemiología , Prevalencia , Infecciones Urinarias/epidemiología , Infecciones Urinarias/microbiología , Infecciones Urinarias/fisiopatología , Infecciones Urinarias/terapia
3.
PLoS One ; 14(1): e0209909, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30645599

RESUMEN

Dementia is a neurological and cognitive condition that affects millions of people around the world. At any given time in the United Kingdom, 1 in 4 hospital beds are occupied by a person with dementia, while about 22% of these hospital admissions are due to preventable causes. In this paper we discuss using Internet of Things (IoT) technologies and in-home sensory devices in combination with machine learning techniques to monitor health and well-being of people with dementia. This will allow us to provide more effective and preventative care and reduce preventable hospital admissions. One of the unique aspects of this work is combining environmental data with physiological data collected via low cost in-home sensory devices to extract actionable information regarding the health and well-being of people with dementia in their own home environment. We have worked with clinicians to design our machine learning algorithms where we focused on developing solutions for real-world settings. In our solutions, we avoid generating too many alerts/alarms to prevent increasing the monitoring and support workload. We have designed an algorithm to detect Urinary Tract Infections (UTI) which is one of the top five reasons of hospital admissions for people with dementia (around 9% of hospital admissions for people with dementia in the UK). To develop the UTI detection algorithm, we have used a Non-negative Matrix Factorisation (NMF) technique to extract latent factors from raw observation and use them for clustering and identifying the possible UTI cases. In addition, we have designed an algorithm for detecting changes in activity patterns to identify early symptoms of cognitive decline or health decline in order to provide personalised and preventative care services. For this purpose, we have used an Isolation Forest (iForest) technique to create a holistic view of the daily activity patterns. This paper describes the algorithms and discusses the evaluation of the work using a large set of real-world data collected from a trial with people with dementia and their caregivers.


Asunto(s)
Actividades Cotidianas , Demencia/fisiopatología , Aprendizaje Automático , Infecciones Urinarias/diagnóstico , Anciano , Demencia/terapia , Femenino , Hospitalización , Humanos , Masculino , Persona de Mediana Edad , Reino Unido , Infecciones Urinarias/fisiopatología , Infecciones Urinarias/terapia
4.
J Pediatr Urol ; 14(1): 54.e1-54.e6, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28974365

RESUMEN

BACKGROUND: Parasacral transcutaneous electrical nerve stimulation (TENS) has emerged as an effective treatment for overactive bladder (OAB) in view of its high success rates in improving lower urinary tract symptoms and constipation, with no direct side effects. However, the clinical characteristics associated with the outcomes remain to be established. OBJECTIVE: The aim of this study was to evaluate potential predictors of outcome in children with OAB treated using parasacral TENS. STUDY DESIGN: This was a prospective study of children with symptoms of isolated OAB, enrolled consecutively to the study and treated with parasacral TENS (figure). Isolated OAB was defined as the presence of urinary urgency with no signs of dysfunctional voiding. The symptoms were considered completely resolved when a patient's parents/guardians or the patients themselves reported a 100% improvement. Parasacral TENS was performed twice weekly for a total of 20 sessions of 20 min each at 10 Hz. The potential predictive factors evaluated were: sex, age, daytime incontinence, nocturia, a prior history of urinary tract infection, the presence of nocturnal enuresis, constipation and holding maneuvers. RESULTS: Eighty-three patients with a mean age of 7.8 ± 2.8 years were included in the study. Complete resolution of symptoms was achieved in 47 (56.6%). Following parasacral TENS treatment, a significant response was reported in 96.4% of cases. Of the 55 patients with nocturnal enuresis, partial resolution was achieved in 30 cases (54.5%), with a statistically significant association between nocturnal enuresis and the patient's response to treatment (p < 0.004; OR = 4.4, 95% CI 1.5-12.5). No other factor was associated with response to treatment. DISCUSSION: To the best of our knowledge, this association between nocturnal enuresis and failure to respond to parasacral TENS treatment for lower urinary tract dysfunction has not previously been reported. The identification of factors capable of predicting therapeutic failure may allow professionals to select those specific patients who would benefit from a multimodal approach in the treatment of this pathology, which has such a significant impact on the quality of life of affected patients. CONCLUSIONS: Nocturnal enuresis was the only symptom associated with a poor outcome following parasacral TENS treatment in children with OAB.


Asunto(s)
Enuresis Nocturna/epidemiología , Estimulación Eléctrica Transcutánea del Nervio/métodos , Vejiga Urinaria Hiperactiva/terapia , Infecciones Urinarias/epidemiología , Adolescente , Niño , Preescolar , Estudios de Cohortes , Estudios de Seguimiento , Humanos , Incidencia , Región Lumbosacra , Masculino , Enuresis Nocturna/fisiopatología , Valor Predictivo de las Pruebas , Estudios Prospectivos , Medición de Riesgo , Resultado del Tratamiento , Vejiga Urinaria Hiperactiva/diagnóstico , Incontinencia Urinaria/epidemiología , Incontinencia Urinaria/fisiopatología , Infecciones Urinarias/fisiopatología
5.
J Altern Complement Med ; 23(6): 471-478, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28414519

RESUMEN

OBJECTIVE: Adjuvants or alternatives to antibiotics in urinary tract infections (UTIs) during pregnancy seem advisable because of possible fetal stress. The present study assessed the effectiveness of a food supplement containing L-methionine and Hibiscus sabdariffa L. and Boswellia serrata Roxb. extracts as a treatment for symptomatic UTIs in pregnancy. DESIGN: Pregnant patients with symptomatic cystitis were screened for UTIs in three different clinical centers. Those unwilling to take antibiotics were offered two alternative treatments: (A) a 1-week treatment with the food supplement or (B) a week in which they were advised to increase their fluid consumption to more than 1.5 L daily. After 1 week, group B patients who still had positive urine cultures (UCs) or had no UC performed took the food supplement for an additional week. UCs were performed on all patients at the first visit (w0) and on most of them at 7 days (w1). Patients who were still positive at w1 or had no UC performed at w1 had UC performed 14 days (w2) thereafter. RESULTS: Of 264 pregnant women enrolled, 216 joined group A, while 48 joined group B. At w1, 70.0% of group A patients and 43.2% of those in group B had negative UCs (p = 0.003). The reduction of bacterial load was 42.2% ± 8.0% and 4.5% ± 9.2%, respectively (p < 0.0001). At w1, symptoms disappeared in 135 patients (62.5%) in group A and 22 patients (45.8%) in group B (p = 0.03). At w2, 30 of 32 group B patients who switched to taking the supplement for the second week had negative UCs, including 20 who had been positive at w1. At w2, all group A patients had negative UCs. No side effects were reported. CONCLUSIONS: The food supplement provided effective treatment and might be an adjuvant or alternative to antibiotic therapy of symptomatic UTI in pregnancy.


Asunto(s)
Suplementos Dietéticos , Metionina/uso terapéutico , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Infecciones Urinarias/tratamiento farmacológico , Adulto , Boswellia/química , Femenino , Hibiscus/química , Humanos , Extractos Vegetales/uso terapéutico , Embarazo , Complicaciones Infecciosas del Embarazo/fisiopatología , Estudios Prospectivos , Infecciones Urinarias/fisiopatología , Adulto Joven
6.
Biomed Pharmacother ; 84: 366-372, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27668536

RESUMEN

The solitary kidney (SK) undergoes adaptive phenomena of hyperfunction and hyperfiltration. These secondary adaptive phenomena can make it more vulnerable to potentially nephrotoxic therapies. Adverse reactions of the kidneys to ciprofloxacin are rare, but sometimes severe. Therefore, our study sought to assess the reactions to ciprofloxacin of patients with solitary kidney (SK) and urinary tract infection (UTI) by means of urinary biomarkers. We studied 19 patients with SK and urinary tract infection (UTI) who had been administered a 7-day treatment with intravenous ciprofloxacin. Urinary N-acetyl-beta-d-glucosaminidase, alpha 1-microglobulin, and estimated glomerular filtration rate (eGFR) of these patients were measured at the initiation and at the end of treatment. In 47.37% patients NAG diminished under ciprofloxacin treatment. This observation has the significance of favourable evolution of the tubulointerstitial lesions caused by UTI and lack of nephrotoxic effects; 52.63% cases presented an increase of urinary NAG, a fact that suggests a nephrotoxic effect of ciprofloxacin. The evolution of urinary alpha 1-microglobulin was similar to that one of urinary NAG. Only one of three cases with chronic kidney disease (CKD) stage 5 presented acute kidney injury, associated with increase in the tubular markers. In spite of the high variability of the urinary biomarkers, UTI evolved favourably in these cases; eGFR increased in 16 out of 19 patients, a fact which is indicative of a good outcome of renal function, even in patients with elevated levels of the tubular damage biomarkers. This observation supports the hypothesis that eGFR may be dissociated from the biomarkers which assess tubular injury. In SK patients the occurrence of AKI is not frequent, although the urinary biomarkers rise in some patients treated with ciprofloxacin. This is related not only to the nephrotoxic effect of the drug, but probably to the association of other factors (allergy, individual susceptibility). In SK patients, renal tubular biomarkers, especially NAG, allow monitoring of tubular injury and impose caution in prescribing ciprofloxacin treatment, mainly to patients at risk. Ciprofloxacin is relatively safe regarding its nephrotoxicity, while caution is required in vulnerable patients.


Asunto(s)
Ciprofloxacina/uso terapéutico , Riñón/anomalías , Infecciones Urinarias/tratamiento farmacológico , Acetilglucosaminidasa/orina , alfa-Globulinas/orina , Ciprofloxacina/farmacología , Femenino , Tasa de Filtración Glomerular/efectos de los fármacos , Humanos , Riñón/efectos de los fármacos , Riñón/patología , Riñón/fisiopatología , Masculino , Persona de Mediana Edad , Infecciones Urinarias/patología , Infecciones Urinarias/fisiopatología , Infecciones Urinarias/orina
7.
Am J Clin Nutr ; 103(6): 1434-42, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27251185

RESUMEN

BACKGROUND: Urinary tract infections (UTIs) are among the most common bacterial infections and are often treated with antibiotics. Concerns about multidrug-resistant uropathogens have pointed to the need for safe and effective UTI-prevention strategies such as cranberry consumption. OBJECTIVE: We assessed the effects of the consumption of a cranberry beverage on episodes of clinical UTIs. DESIGN: In this randomized, double-blind, placebo-controlled, multicenter clinical trial, women with a history of a recent UTI were assigned to consume one 240-mL serving of cranberry beverage/d (n = 185) or a placebo (n = 188) beverage for 24 wk. The primary outcome was the clinical UTI incidence density, which was defined as the total number of clinical UTI events (including multiple events per subject when applicable) per unit of observation time. RESULTS: The dates of the random assignment of the first subject and the last subject's final visit were February 2013 and March 2015, respectively. The mean age was 40.9 y, and characteristics were similar in both groups. Compliance with study product consumption was 98%, and 86% of subjects completed the treatment period in both groups. There were 39 investigator-diagnosed episodes of clinical UTI in the cranberry group compared with 67 episodes in the placebo group (antibiotic use-adjusted incidence rate ratio: 0.61; 95% CI: 0.41, 0.91; P = 0.016). Clinical UTI with pyuria was also significantly reduced (incidence rate ratio: 0.63; 95% CI: 0.40, 0.97; P = 0.037). One clinical UTI event was prevented for every 3.2 woman-years (95% CI: 2.0, 13.1 woman-years) of the cranberry intervention. The time to UTI with culture positivity did not differ significantly between groups (HR: 0.97; 95% CI: 0.56, 1.67; P = 0.914). CONCLUSION: The consumption of a cranberry juice beverage lowered the number of clinical UTI episodes in women with a recent history of UTI. This study was registered at clinicaltrials.gov as NCT01776021.


Asunto(s)
Bebidas , Frutas , Infecciones Urinarias/prevención & control , Vaccinium macrocarpon , Adulto , Anciano , Método Doble Ciego , Femenino , Humanos , Persona de Mediana Edad , Fitoterapia , Placebos , Piuria , Infecciones Urinarias/epidemiología , Infecciones Urinarias/fisiopatología
8.
Urologiia ; (3 Suppl 3): 65-76, 2016 Aug.
Artículo en Ruso | MEDLINE | ID: mdl-28247619

RESUMEN

This review outlines characteristics of medications most commonly used for preventing recurrent lower urinary tract infection (UTI). It shows that the treatment and prophylaxis of UTI should be comprehensive and include the restoration of the normal urogenital tract anatomy and use in addition to antibacterial and anti-inflammatory drugs, agents, normalizing the function of the lower urinary tract, as well as drugs for local and systemic immunoprophylaxis, protection of the urothelium from recurrent infection, local hormone replacement therapy in menopause, and dietary supplements to acidify the urine.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones Urinarias/prevención & control , Infecciones Urinarias/terapia , Antiinflamatorios/uso terapéutico , Femenino , Terapia de Reemplazo de Hormonas , Humanos , Masculino , Persona de Mediana Edad , Fitoterapia , Recurrencia , Vejiga Urinaria/patología , Sistema Urinario/patología , Infecciones Urinarias/patología , Infecciones Urinarias/fisiopatología
9.
Chin J Integr Med ; 22(7): 510-7, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25491541

RESUMEN

OBJECTIVE: To explore the correlation between single acupoints used and the recurrence rate of cystitis among cystitis-prone women receiving acupuncture as a prophylactic treatment. METHODS: In all, 58 cystitis-prone women were included in the analysis. Customised acupuncture treatments were given twice a week, over 4 weeks. The main effect parameter was the number of cystitis episodes during the 6-month observation time. Residual urine was measured at baseline, 2, 4 and 6 months using portable ultrasound equipment. Sympathetic and vagotone nerve activities were measured by using skin conductance and respiratory sinus arrhythmia, respectively. RESULTS: The main acupoints used for patients with Kidney (Shen) qi/yang deficiency were Shenshu (BL23), Taixi (KI3), Zhongji (CV3), Sanyinjiao (SP6) and Pangguangshu (BL28), compared with Taichong (LR3), CV3, BL28, Yinlingquan (SP9) and SP6 for Liver (Gan) qi stagnation, and SP6, CV3, BL28, Zusanli (ST36) and SP9 for Spleen (Pi) qi/yang deficiency patients. The combination BL23 and KI3 were used in 16 women, 13 of which were Kidney pattern related patients. When used, the number of symptomatic episodes were reduced to a third compared with what occurred in the 42 women where this combination was not used (3/16 vs. 28/42, P<0.05). BL23 application correlated to a significant reduction in residual urine measured a few days after treatment. Patients with the pattern of Spleen qi/yang deficiency had an initial increase in residual urine after treatments. CONCLUSION: Treating Kidney pattern related patients with the combination of BL23 and KI3 resulted in far better outcome than other points/combination of points for other Chinese medicine diagnoses. The acupoint SP6 may be less indicated than previously assumed when treating cystitis-prone women prophylactically.


Asunto(s)
Puntos de Acupuntura , Terapia por Acupuntura , Cistitis/fisiopatología , Cistitis/terapia , Cistitis/prevención & control , Cistitis/orina , Femenino , Humanos , Recurrencia , Síndrome , Infecciones Urinarias/fisiopatología , Infecciones Urinarias/prevención & control , Infecciones Urinarias/terapia , Infecciones Urinarias/orina , Nervio Vago/fisiopatología
10.
Sci Rep ; 5: 14542, 2015 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-26444930

RESUMEN

Benign prostatic hyperplasia (BPH) is one of the most common diseases in middle-aged and elderly men. In the present study, we aimed to compare the efficacy and safety of thulium laser resection of the prostate (TMLRP) with either transurethral plasmakinetic resection of the prostate (TUPKP) or transurethral resection of the prostate (TURP). A literature search was performed, eventually, 14 studies involving 1587 patients were included. Forest plots were produced by using Revman 5.2.0 software. Our meta-analysis showed that operation time, decrease in hemoglobin level, length of hospital stay, catheterization time, and development of urethral stricture significantly differed, whereas the transitory urge incontinence rate, urinary tract infection rate, and recatheterization rate did not significantly differ between TMLRP and either TURP or TUPKP. The blood transfusion rate was significantly different between TMLRP and TURP, but not between TMLRP and TUPKP. In addition, the retrograde ejaculation rate between TMLRP and TURP did not significantly differ. At 1, 3, 6, and 12 months of postoperative follow-up, the maximum flow rate, post-void residual, quality of life, and International Prostate Symptom Score did not significantly differ among the procedures. Thus, the findings of this study indicate that TMLRP may be a safe and feasible alternative.


Asunto(s)
Láseres de Estado Sólido/uso terapéutico , Hiperplasia Prostática/cirugía , Calidad de Vida/psicología , Resección Transuretral de la Próstata/métodos , Anciano , Humanos , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Tempo Operativo , Gases em Plasma/química , Próstata/patología , Próstata/cirugía , Hiperplasia Prostática/patología , Hiperplasia Prostática/psicología , Hiperplasia Prostática/rehabilitación , Tulio/química , Resección Transuretral de la Próstata/efectos adversos , Resección Transuretral de la Próstata/psicología , Estrechez Uretral/etiología , Estrechez Uretral/fisiopatología , Incontinencia Urinaria de Urgencia/etiología , Incontinencia Urinaria de Urgencia/fisiopatología , Infecciones Urinarias/etiología , Infecciones Urinarias/fisiopatología
11.
Antimicrob Agents Chemother ; 59(12): 7593-6, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26416859

RESUMEN

The emergence of multidrug-resistant (MDR) uropathogens is making the treatment of urinary tract infections (UTIs) more challenging. We sought to evaluate the accuracy of empiric therapy for MDR UTIs and the utility of prior culture data in improving the accuracy of the therapy chosen. The electronic health records from three U.S. Department of Veterans Affairs facilities were retrospectively reviewed for the treatments used for MDR UTIs over 4 years. An MDR UTI was defined as an infection caused by a uropathogen resistant to three or more classes of drugs and identified by a clinician to require therapy. Previous data on culture results, antimicrobial use, and outcomes were captured from records from inpatient and outpatient settings. Among 126 patient episodes of MDR UTIs, the choices of empiric therapy against the index pathogen were accurate in 66 (52%) episodes. For the 95 patient episodes for which prior microbiologic data were available, when empiric therapy was concordant with the prior microbiologic data, the rate of accuracy of the treatment against the uropathogen improved from 32% to 76% (odds ratio, 6.9; 95% confidence interval, 2.7 to 17.1; P < 0.001). Genitourinary tract (GU)-directed agents (nitrofurantoin or sulfa agents) were equally as likely as broad-spectrum agents to be accurate (P = 0.3). Choosing an agent concordant with previous microbiologic data significantly increased the chance of accuracy of therapy for MDR UTIs, even if the previous uropathogen was a different species. Also, GU-directed or broad-spectrum therapy choices were equally likely to be accurate. The accuracy of empiric therapy could be improved by the use of these simple rules.


Asunto(s)
Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana Múltiple , Nitrofurantoína/uso terapéutico , Sulfanilamidas/uso terapéutico , Infecciones Urinarias/tratamiento farmacológico , Sistema Urinario/efectos de los fármacos , Bases de Datos Factuales , Investigación Empírica , Humanos , Pruebas de Sensibilidad Microbiana , Resultado del Tratamiento , Estados Unidos , United States Department of Veterans Affairs , Sistema Urinario/microbiología , Sistema Urinario/fisiopatología , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/microbiología , Infecciones Urinarias/fisiopatología
12.
Br J Gen Pract ; 65(633): e217-23, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25824181

RESUMEN

BACKGROUND: The prevalence of targeted and serendipitous treatment for, and associated recovery from, urinary tract infection (UTI) in pre-school children is unknown. AIM: To determine the frequency and suspicion of UTI in children who are acutely ill, along with details of antibiotic prescribing, its appropriateness, and whether that appropriateness impacted on symptom improvement and recovery. DESIGN AND SETTING: Prospective observational cohort study in primary care sites in urban and rural areas in England and Wales. METHOD: Systematic urine sampling from children aged <5 years presenting in primary care with acute illness with culture in NHS laboratories. RESULTS: Of 6079 children's urine samples, 339 (5.6%) met laboratory criteria for UTI and 162 (47.9%) were prescribed antibiotics at the initial consultation. In total, 576/7101 (8.1%) children were suspected of having a UTI prior to urine sampling, including 107 of the 338 with a UTI (clinician sensitivity 31.7%). Children with a laboratory-diagnosed UTI were more likely to be prescribed antibiotics when UTI was clinically suspected than when it was not (86.0% versus 30.3%, P<0.001). Of 231 children with unsuspected UTI, 70 (30.3%) received serendipitous antibiotics (that is, antibiotics prescribed for a different reason). Overall, 176 (52.1%) children with confirmed UTI did not receive any initial antibiotic. Organism sensitivity to the prescribed antibiotic was higher when UTI was suspected than when treated serendipitously (77.1% versus 26.0%; P<0.001). Children with UTI prescribed appropriate antibiotics at the initial consultation improved a little sooner than those with a UTI who were not prescribed appropriate antibiotics initially (3.5 days versus 4.0 days; P = 0.005). CONCLUSION: Over half of children with UTI on culture were not prescribed antibiotics at first presentation. Serendipitous UTI treatment was relatively common, but often inappropriate to the organism's sensitivity. Methods for improved targeting of antibiotic treatment in children who are acutely unwell are urgently needed.


Asunto(s)
Antiinfecciosos Urinarios/uso terapéutico , Atención Primaria de Salud , Infecciones Urinarias , Preescolar , Inglaterra/epidemiología , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Evaluación de Necesidades , Pautas de la Práctica en Medicina/normas , Pautas de la Práctica en Medicina/estadística & datos numéricos , Prevalencia , Atención Primaria de Salud/métodos , Atención Primaria de Salud/normas , Atención Primaria de Salud/estadística & datos numéricos , Estudios Prospectivos , Resultado del Tratamiento , Urinálisis/métodos , Urinálisis/estadística & datos numéricos , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/epidemiología , Infecciones Urinarias/fisiopatología , Gales/epidemiología
13.
Urologia ; 81(2): 93-8, 2014.
Artículo en Italiano | MEDLINE | ID: mdl-24874306

RESUMEN

Infection urinary stones resulting from urease-producing bacteria are composed by struvite and/or carbonate apatite. Bacterial urease splits urea and promotes the formation of ammonia and carbon dioxide leading to urine alkalinization and formation of phosphate salts. Proteus species are urease-producers, whereas a limited number of strains of other Gram negative and positive species may produce urease. Ureaplasma urealyticum and Corynebacterium urealyticum are urease-producers that are not isolated by conventional urine cultures, but require specific tests for identification. Primary treatment requires surgical removal of stones as complete as possible. Extracorporeal and endoscopic treatments are usually preferred, while open surgery is actually limited to few selected cases. Residual stones or fragments should be treated by chemolysis via ureteral catheter or nephrostomy or administration of citrate salts in order to achieve a stone-free renal unit. Postoperatively, recurrent urinary tract infection should be treated with appropriate antibiotic treatment although long-term antibiotic prophylaxis can cause resistance. Urinary acidification has been proposed for the prophylaxis of infection stones, but long-term acidification is difficult to achieve in urine infected by urease-producing bacteria. Urease inhibitors lead to prevention and/or dissolution of stones and encrustations in patients with infection by urea-splitting bacteria, but their use is limited by their toxicity. The administration of citrate salts involves an increase of the value of nucleation pH (pHn), that is the pH value at which calcium and magnesium phosphate crystallization occurs, in a greater way than the corresponding increase in the urinary pH due to its alkalinizing effect and resulting in a reduction of the risk of struvite crystallization. In conclusion prevention of the recurrence of infection stones can be achieved by an integrated approach tailored on the single patient. Complete clearance of the stone must be achieved by primary surgical procedure and residual fragments should be extensively treated. In the case of persistent infection, conservative measures, such as acidification and urease inhibitors or citrate administration, should be adopted to minimize its effect on urinary saturation with respect to struvite.


Asunto(s)
Cálculos Urinarios/etiología , Infecciones Urinarias/complicaciones , Cloruro de Amonio/uso terapéutico , Antibacterianos/uso terapéutico , Ácido Ascórbico/uso terapéutico , Proteínas Bacterianas/antagonistas & inhibidores , Proteínas Bacterianas/metabolismo , Biopelículas , Citratos/uso terapéutico , Cristalización , Infecciones por Bacterias Gramnegativas/complicaciones , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/microbiología , Infecciones por Bacterias Grampositivas/complicaciones , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Infecciones por Bacterias Grampositivas/microbiología , Humanos , Concentración de Iones de Hidrógeno , Ácidos Hidroxámicos/uso terapéutico , Litotricia , Compuestos de Magnesio/metabolismo , Nefrostomía Percutánea , Fosfatos/metabolismo , Fitoterapia , Citrato de Sodio , Estruvita , Ureasa/antagonistas & inhibidores , Ureasa/metabolismo , Cálculos Urinarios/epidemiología , Cálculos Urinarios/prevención & control , Cálculos Urinarios/cirugía , Cálculos Urinarios/terapia , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Infecciones Urinarias/fisiopatología , Orina/química , Urolitiasis/epidemiología , Urolitiasis/etiología , Urolitiasis/metabolismo , Urolitiasis/prevención & control
14.
Arch Gynecol Obstet ; 289(3): 601-8, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24057079

RESUMEN

PURPOSE: To assess the effects of the combination of pelvic floor rehabilitation, intravaginal estriol and Lactobacillus acidophli administration on stress urinary incontinence (SUI), urogenital atrophy and recurrent urinary tract infections in postmenopausal women. METHODS: 136 postmenopausal women with urogenital aging symptoms were enrolled in this prospective randomized study. PATIENTS: randomly divided into two groups and each group consisted of 68 women. INTERVENTIONS: Subjects in the triple therapy (group I) received 1 intravaginal ovule containing 30 mcg estriol and Lactobacilli acidophili (50 mg lyophilisate containing at least 100 million live bacteria) such as once daily for 2 weeks and then two ovules once weekly for a total of 6 months as maintenance therapy plus pelvic floor rehabilitation. Subjects in the group II received one intravaginal estriol ovule (1 mg) plus pelvic floor rehabilitation in a similar regimen. MEAN OUTCOME MEASURES: We evaluated urogenital symptomatology, urine cultures, colposcopic findings, urethral cytologic findings, urethral pressure profiles and urethrocystometry before, as well as after 6 months of treatment. RESULTS: After therapy, the symptoms and signs of urogenital atrophy significantly improved in both groups. 45/59 (76.27%) of the group I and 26/63 (41.27%) of the group II referred a subjective improvement of their incontinence. In the patients treated by triple therapy with lactobacilli, estriol plus pelvic floor rehabilitation, we observed significant improvements of colposcopic findings, and there were statistically significant increases in mean maximum urethral pressure, in mean urethral closure pressure, as well as in the abdominal pressure transmission ratio to the proximal urethra. CONCLUSIONS: Our results showed that triple therapy with L. acidophili, estriol plus pelvic floor rehabilitation was effective and should be considered as first-line treatment for symptoms of urogenital aging in postmenopausal women.


Asunto(s)
Envejecimiento/fisiología , Estriol/uso terapéutico , Lactobacillus , Incontinencia Urinaria de Esfuerzo/terapia , Infecciones Urinarias/terapia , Sistema Urogenital/patología , Sistema Urogenital/fisiopatología , Administración Intravaginal , Anciano , Atrofia/fisiopatología , Atrofia/terapia , Terapia Combinada/métodos , Terapia por Estimulación Eléctrica , Estriol/administración & dosificación , Terapia por Ejercicio , Femenino , Humanos , Persona de Mediana Edad , Diafragma Pélvico/fisiopatología , Posmenopausia , Estudios Prospectivos , Recurrencia , Resultado del Tratamiento , Incontinencia Urinaria de Esfuerzo/fisiopatología , Infecciones Urinarias/fisiopatología
15.
Med Arch ; 67(2): 88-90, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24341050

RESUMEN

BACKGROUND: GDM is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy. Pregnancy causes some insulin resistance in all women, but only a few develop GDM. OBJECTIVE: To test the hypothesis that women with GDM have impaired regulation of blood iron storage and transport, decreased renal function due to decreased glomerular filtration rate and occurrence of urinary tract infection (UTI). STUDY DESIGN AND METHODS: Incidence of blood iron storage was investigated in n=30 pregnant kosovar women with GDM after mild of pregnancy and in n=30 pregnant women without GDM (years 2010-2012). RESULTS AND DISCUSSION: Baby weights, both systolic and diastolic BP, creatinine, albumin, lymphocytes, monocytes, WBC and granulocytes in both groups were within their normal ranges in both groups. Compared to control group, glucose was higher in women with GDM (mean +/- SD: 7.43 +/- 2.23 mg/dL vs. 4.33 +/- 0.63 mg/dL; P < 0.001). Women with GDM had also higher RBC (mean +/- SD: 4.4 +/- 0.8% vs. 3.8 +/- 0.3%; P < 0.005) and HGB (mean +/- SD: 13.0 +/- 3.2 g/dL vs. 11.2 +/- 1.4 mg/dL; P < 0.05), and decreased renal functionality (MDRD-GFR: 92.8 +/- 25.8 g/dL vs. 108.2 +/- 38.2 g/dL; P < .05). CONCLUSION: There is a potential association between iron status and GDM. The role of iron from diet and/or from supplementation in GDM pathogenesis needs still to be examined. In addition we have observed a decrease of glomerular filtration rate in women with GDM. Due to the lack of studies on the relationships between GDM and UTI, and to the retrospective design of the present investigation, it is difficult to establish whether UTI may be a GDM causal factor or a consequence of GDM symptoms, signs and/or of its correlated pathologies.


Asunto(s)
Glucemia , Diabetes Gestacional , Hemocromatosis/epidemiología , Infecciones Urinarias/epidemiología , Adulto , Peso al Nacer , Glucemia/análisis , Glucemia/metabolismo , Causalidad , Diabetes Gestacional/sangre , Diabetes Gestacional/diagnóstico , Diabetes Gestacional/epidemiología , Diabetes Gestacional/fisiopatología , Femenino , Tasa de Filtración Glomerular , Hemocromatosis/metabolismo , Humanos , Recién Nacido , Insulina/metabolismo , Hierro/análisis , Hierro/metabolismo , Kosovo , Embarazo , Estudios Retrospectivos , Infecciones Urinarias/fisiopatología
16.
Int Braz J Urol ; 39(1): 118-26; discussion 127, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23489504

RESUMEN

PURPOSE: To evaluate the efficacy of standard and biofeedback bladder control training (BCT) on the resolution of dysfunctional elimination syndrome (primary outcome), and on the reduction of urinary tract infections (UTI) and the use of medications such as antibacterial prophylaxis and/or anticholinergic/alpha-blockers (secondary outcome) in girls older than aged least 5 years. MATERIALS AND METHODS: 72 girls, median age of 8 years (interquartile range, IQR 7-10) were subjected to standard BCT (cognitive, behavioural and constipation treatment) and 12 one-hour sessions of animated biofeedback using interactive computer games within 8 weeks. Fifty patients were reevaluated after median 11 (IQR, 6-17) months. Effectiveness of BCT was determined by reduction of dysfunctional voiding score (DVS), daytime urinary incontinence (DUI), constipation, UTI, nocturnal enuresis (NE), post void residual (PVR), and improvements in bladder capacity and uroflow/EMG patterns. RESULTS: BCT resulted in significant normalization of DUI, NE, constipation, bladder capacity, uroflow/EMG, while decrease of PVR didn't reach statistical significance. In addition, the incidence of UTI, antibacterial prophylaxis and medical urotherapy significantly decreased. There were no significant differences in DVS, DVI, NE, bladder capacity and voiding pattern at the end of the BCT and at the time of reevaluation. The success on BCT was supported by parenteral perception of the treatment response in 63.9% and full response in additional 15.3% of the patients. CONCLUSION: Combination of standard and biofeedback BCT improved dysfunctional elimination syndrome and decreased UTI with discontinuation of antibacterial prophylaxis and/or anticholinergic/alpha-blockers in the majority of the patients. Better training results are expected in patients with higher bladder wall thickness as well as in those with vesicoureteral reflux, while presence of nocturnal enuresis may be a negative predictor of the training effect.


Asunto(s)
Síntomas del Sistema Urinario Inferior/terapia , Vejiga Urinaria/fisiopatología , Infecciones Urinarias/terapia , Antagonistas Adrenérgicos alfa/uso terapéutico , Antiinfecciosos Urinarios/uso terapéutico , Biorretroalimentación Psicológica , Niño , Antagonistas Colinérgicos/uso terapéutico , Terapia por Ejercicio/métodos , Femenino , Humanos , Síntomas del Sistema Urinario Inferior/fisiopatología , Diafragma Pélvico , Estadísticas no Paramétricas , Factores de Tiempo , Resultado del Tratamiento , Infecciones Urinarias/fisiopatología
17.
Int. braz. j. urol ; 39(1): 118-127, January-February/2013. tab, graf
Artículo en Inglés | LILACS | ID: lil-670373

RESUMEN

Purpose To evaluate the efficacy of standard and biofeedback bladder control training (BCT) on the resolution of dysfunctional elimination syndrome (primary outcome), and on the reduction of urinary tract infections (UTI) and the use of medications such as antibacterial prophylaxis and/or anticholinergic/alpha-blockers (secondary outcome) in girls older than aged least 5 years. Materials and Methods 72 girls, median age of 8 years (interquartile range, IQR 7-10) were subjected to standard BCT (cognitive, behavioural and constipation treatment) and 12 one-hour sessions of animated biofeedback using interactive computer games within 8 weeks. Fifty patients were reevaluated after median 11 (IQR, 6-17) months. Effectiveness of BCT was determined by reduction of dysfunctional voiding score (DVS), daytime urinary incontinence (DUI), constipation, UTI, nocturnal enuresis (NE), post void residual (PVR), and improvements in bladder capacity and uroflow/EMG patterns. Results BCT resulted in significant normalization of DUI, NE, constipation, bladder capacity, uroflow/EMG, while decrease of PVR didn't reach statistical significance. In addition, the incidence of UTI, antibacterial prophylaxis and medical urotherapy significantly decreased. There were no significant differences in DVS, DUI, NE, bladder capacity and voiding pattern at the end of the BCT and at the time of reevaluation. The success on BCT was supported by parenteral perception of the treatment response in 63.9% and full response in additional 15.3% of the patients. Conclusion Combination of standard and biofeedback BCT improved dysfunctional elimination syndrome and decreased UTI with discontinuation of antibacterial prophylaxis and/or anticholinergic/alpha-blockers in the majority of the patients. Better training results are expected in patients with higher bladder wall thickness as well as in those with vesicoureteral reflux, ...


Asunto(s)
Niño , Femenino , Humanos , Síntomas del Sistema Urinario Inferior/terapia , Vejiga Urinaria/fisiopatología , Infecciones Urinarias/terapia , Antagonistas Adrenérgicos alfa/uso terapéutico , Antiinfecciosos Urinarios/uso terapéutico , Biorretroalimentación Psicológica , Antagonistas Colinérgicos/uso terapéutico , Terapia por Ejercicio/métodos , Síntomas del Sistema Urinario Inferior/fisiopatología , Diafragma Pélvico , Estadísticas no Paramétricas , Factores de Tiempo , Resultado del Tratamiento , Infecciones Urinarias/fisiopatología
18.
Ter Arkh ; 84(12): 97-102, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-23479999

RESUMEN

AIM: To study the clinical aspects of using the furasidine potassium in combination with basic magnesium carbonate (furamag) and phosphomycin trometamol (monural) as antimicrobial agents most frequently used in outpatient practice during combination therapy for acute and chronic urinary tract (UT) diseases. SUBJECTS AND METHODS: To study the specific features of therapy for UT infections, 60 patients were randomized to 2 groups: 1) 30 patients received a course therapy with furasidine potassium (furamag) in a dose of 50 mg t.i.d. for 7 days (a study group) and 2) 30 had phosphomycin trometamol (monural) in a single dose of 3 g for pulse therapy (a comparison group). The clinical efficacy of the drugs, symptom disappearance rates, bacterial changes, and laboratory and instrumental findings were assessed. The patient's opinion was mainly used to evaluate outpatient pharmacoeconomic efficiency. Patient compliance with the given therapy was estimated by taking into account the specific features of prehospital care. RESULTS: During therapy, both groups showed positive clinical changes. In the study group, the symptoms of dysuria resolved 0.5 days more quickly and a complete clinical remission was achieved 0.8 days more promptly; the latter within the first 72 hours was achieved by 7.5% more of the patients; the symptoms of bacteriuria resolved 0.6 days more rapidly. With the similar average price of the packs of furasidine potassium (furamag) 50 mg (30 capsules) and phosphomycin trometamol (monural) 1 g (a sachet) being 350 and 370 rubles, the average costs of required treatment were 482 and 546 rubles, respectively. No case of adverse reactions was recorded during the study. CONCLUSION: Patients with infectious and inflammatory diseases of UT should be given furasidine potassium in the standard dose of 50 mg t.i.d for 7 days.


Asunto(s)
Antiinfecciosos , Bacterias/efectos de los fármacos , Fosfomicina , Infecciones del Sistema Genital , Infecciones Urinarias , Adulto , Atención Ambulatoria/economía , Atención Ambulatoria/métodos , Atención Ambulatoria/normas , Antiinfecciosos/administración & dosificación , Antiinfecciosos/efectos adversos , Antiinfecciosos/economía , Actitud del Personal de Salud , Bacterias/clasificación , Bacterias/aislamiento & purificación , Técnicas Bacteriológicas/métodos , Costos de los Medicamentos , Quimioterapia Combinada , Femenino , Fosfomicina/administración & dosificación , Fosfomicina/efectos adversos , Fosfomicina/economía , Fumaratos/administración & dosificación , Fumaratos/efectos adversos , Fumaratos/economía , Humanos , Masculino , Cumplimiento de la Medicación , Pruebas de Sensibilidad Microbiana/métodos , Evaluación de Resultado en la Atención de Salud , Infecciones del Sistema Genital/tratamiento farmacológico , Infecciones del Sistema Genital/microbiología , Infecciones del Sistema Genital/fisiopatología , Resultado del Tratamiento , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Infecciones Urinarias/fisiopatología , Sistema Urogenital/microbiología , Sistema Urogenital/fisiopatología
19.
Arch Gynecol Obstet ; 285(2): 397-403, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21706345

RESUMEN

PURPOSE: To assess the effects of the combination of pelvic floor rehabilitation and intravaginal estriol administration on stress urinary incontinence (SUI), urogenital atrophy and recurrent urinary tract infections in postmenopausal women. METHODS: Two-hundred-six postmenopausal women with urogenital aging symptoms were enrolled in this prospective randomized controlled study. Patients were randomly divided into two groups and each group consisted of 103 women. Subjects in the treatment group received intravaginal estriol ovules, such as 1 ovule (1 mg) once daily for 2 weeks and then 2 ovules once weekly for a total of 6 months as maintenance therapy plus pelvic floor rehabilitation. Subjects in the control group received only intravaginal estriol in a similar regimen. We evaluated urogenital symptomatology, urine cultures, colposcopic findings, urethral cytologic findings, urethral pressure profiles and urethrocystometry before, as well as after 6 months of treatment. RESULTS: After therapy, the symptoms and signs of urogenital atrophy significantly improved in both groups. 61/83 (73.49%) of the treated patients, and only 10/103 (9.71%) of the control patients referred a subjective improvement of their incontinence. In the patients treated by combination therapy with estriol plus pelvic floor rehabilitation, we observed significant improvements of colposcopic findings, and there were statistically significant increases in mean maximum urethral pressure (MUP), in mean urethral closure pressure (MUCP), as well as in the abdominal pressure transmission ratio to the proximal urethra (PTR). CONCLUSIONS: Our results showed that combination therapy with estriol plus pelvic floor rehabilitation was effective and should be considered as a first-line treatment for symptoms of urogenital aging in postmenopausal women.


Asunto(s)
Envejecimiento , Estriol/uso terapéutico , Terapia por Ejercicio , Diafragma Pélvico/fisiopatología , Sistema Urogenital/patología , Sistema Urogenital/fisiopatología , Administración Intravaginal , Análisis de Varianza , Atrofia/tratamiento farmacológico , Atrofia/fisiopatología , Atrofia/rehabilitación , Dispareunia/tratamiento farmacológico , Dispareunia/fisiopatología , Dispareunia/rehabilitación , Terapia por Estimulación Eléctrica , Femenino , Humanos , Persona de Mediana Edad , Posmenopausia , Presión , Uretra/fisiopatología , Vejiga Urinaria/fisiopatología , Incontinencia Urinaria de Esfuerzo/tratamiento farmacológico , Incontinencia Urinaria de Esfuerzo/fisiopatología , Incontinencia Urinaria de Esfuerzo/rehabilitación , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/fisiopatología , Infecciones Urinarias/rehabilitación , Vagina/patología , Vagina/fisiopatología
20.
Urology ; 78(6): 1397-401, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21996110

RESUMEN

OBJECTIVE: To report the long-term follow-up results of patients with Hinman-Allen syndrome (HAS) at our institution. METHODS: The data from 22 children with HAS were retrospectively analyzed. The patients were followed up every 3-6 months with serial physical examinations, voiding charts, urine culture, postvoid residual urine volume determination, serum creatinine measurement, and urinary imaging. The follow-up time was calculated from the day of the first visit to the day of the latest dimercaptosuccinic acid scan. Urotherapy, pharmacotherapy, clean intermittent catheterization, biofeedback therapy, and surgery were performed sequentially and/or combined, depending on the disease course. Renal deterioration was defined as any presence of a new scar or cortical thinning compared with the findings from the first dimercaptosuccinic acid scan. Upper urinary tract deterioration was defined as the persistence or progression of hydronephrosis on ultrasonography. RESULTS: The mean age at referral was 9.18 ± 3.36 years (range 2-14), and the mean follow-up period was 80.90 ± 19.57 months (range 54-144). Conservative therapy resulted in improvement of the bladder function in 14 patients; however, 8 patients required surgery owing to failure of this approach. Asymptomatic bacteriuria developed in one half of the children (n = 11, 50%), and in 6 (22.7%), ≥1 febrile urinary tract infection developed. None of the patients had upper urinary tract deterioration; however, renal deterioration developed in 3 patients (13.6%). The mean creatinine levels had remained stable at the end of the follow-up. CONCLUSION: Close follow-up at a single institution and proactive treatment resulted in successful stabilization of HAS in most of our children with HAS.


Asunto(s)
Enuresis Diurna/terapia , Enuresis Nocturna/terapia , Adolescente , Terapia Conductista , Biorretroalimentación Psicológica , Niño , Preescolar , Creatinina/sangre , Enuresis Diurna/fisiopatología , Enuresis Diurna/psicología , Femenino , Estudios de Seguimiento , Humanos , Hidronefrosis/diagnóstico por imagen , Cateterismo Uretral Intermitente , Riñón/diagnóstico por imagen , Masculino , Enuresis Nocturna/fisiopatología , Enuresis Nocturna/psicología , Pronóstico , Radiografía , Cintigrafía , Insuficiencia Renal/prevención & control , Estudios Retrospectivos , Síndrome , Ultrasonografía , Vejiga Urinaria/diagnóstico por imagen , Infecciones Urinarias/fisiopatología , Urodinámica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA